<DOC>
	<DOCNO>NCT00395603</DOCNO>
	<brief_summary>To compare effectiveness ezetimibe/simvastatin 10/40 daily atorvastatin 80 daily reduce concentration ldl-c endpoint 6 week treatment .</brief_summary>
	<brief_title>Vytorin Treating Uncontrolled Lipids ( VyTUL ) Study ( 0653A-122 )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Ezetimibe</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>Greater 18 year age Treated least last 3 month daily dose atorvastatin 40 mg Existing coronary heart disease cholesterol &gt; 4.0 mmol/l Uncontrolled diabetes Elevated liver function test Elevated creatine kinase ( ck ) Triglycerides ( tg ) &gt; 4.5 mmol/l Drug alcohol dependency within 6 month prior visit 1 Woman receive hormonal therapy maintain stable dose regimen least 8 week willing continue regimen duration study Woman childbearing potential use acceptable method birth control Women pregnant breast feeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>